GM vs GTBP · P/E 7.5, rev $91.65B vs $17.4M cap
General Motors Company (GM) versus GT Biopharma Inc (GTBP) — a side-by-side from cached financials, not a winner call.
General Motors Company (GM) is a auto manufacturers company listed on US.
GT Biopharma Inc (GTBP) is a biotechnology company listed on NASDAQ.
Latest reported GM revenue for 2026-06-30 was $91.65B. Net income was $3.93B. GM currently screens at market cap $51.33B and trailing P/E 7.5.
GTBP does not have a complete income-statement cache yet.
GM currently screens at market cap $51.33B and trailing P/E 7.5. GTBP currently screens at market cap $17.4M.
Not investment advice. Open the GM and GTBP stock pages for the full models.
Not investment advice.